42 results
424B5
COCP
Cocrystal Pharma Inc
27 Aug 20
Prospectus supplement for primary offering
5:24pm
our intellectual property portfolio; and
attracting, hiring and retaining qualified personnel.
Because of the numerous risks and uncertainties
424B5
COCP
Cocrystal Pharma Inc
26 Aug 20
Prospectus supplement for primary offering
5:30pm
our intellectual property portfolio; and
attracting, hiring and retaining qualified personnel.
Because of the numerous risks and uncertainties
8-K
EX-1.1
tie3091a
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
424B5
5hzw2t 4prrw
1 Jul 20
Prospectus supplement for primary offering
4:49pm
8-K
EX-10.1
om5soob4
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
qk6dlgtqv gxav5oeub
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
EX-10.1
5dcz0w3pwe ph9nxf
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
424B5
x3m89d
28 Feb 20
Prospectus supplement for primary offering
1:27pm
424B5
juvuzp
31 Jan 20
Prospectus supplement for primary offering
8:03am
8-K
EX-10.1
c1a03mssvs0lquk2gd
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
424B5
wod7u0kcq
31 Jan 20
Prospectus supplement for primary offering
8:01am
424B5
6iqjnp 3zem
31 Oct 19
Prospectus supplement for primary offering
4:05pm
424B5
x02tymnm2
31 Oct 19
Prospectus supplement for primary offering
4:02pm
424B5
pxlcb78jclt rniw75un
30 Oct 19
Prospectus supplement for primary offering
4:59pm
424B5
kr5 8wqmq
20 Jul 18
Prospectus supplement for primary offering
4:46pm